Your session is about to expire
← Back to Search
Pain Control Techniques for Shoulder Surgery Pain
Study Summary
This trial will compare two different ways of administering pain medication through a continuous nerve block for pain control after total shoulder arthroplasty. The first group will receive the medication through a traditional continuous infusion, and the second group will receive the medication through a new infusion strategy called the 'programmed intermittent bolus' (PIB) technique. The goal of the trial is to see if the PIB technique is better than the traditional continuous infusion with respect to pain control.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a severe lung or breathing problem.I cannot communicate in English.I have a long-term pain condition like fibromyalgia or nerve pain.My health is good to moderately impaired according to ASA standards.I have a blood clotting disorder.I take more than 50 mg of morphine or its equivalent daily.I am an adult.I have been diagnosed with complex regional pain syndrome.
- Group 1: Programmed Intermittent Bolus (PIB)
- Group 2: Continuous Infusion
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities for participants to sign up for this investigation?
"Per the details provided on clinicaltrials.gov, this scientific investigation is in progress and actively recruiting participants after being first published on September 1st 2022 and last modified on September 26th of that same year."
What is the uppermost patient count for this research project?
"Affirmative. Clinicaltrials.gov has information which affirms that this clinical trial, first shared on September 1st 2022, is actively recruiting participants. 110 individuals need to be recruited from a single site."
Share this study with friends
Copy Link
Messenger